InvestorsHub Logo
Followers 44
Posts 10455
Boards Moderated 0
Alias Born 01/13/2016

Re: Cbdpotential post# 72775

Sunday, 08/07/2016 8:48:56 PM

Sunday, August 07, 2016 8:48:56 PM

Post# of 462743
n clinical studies, some sigma-1 receptor agonists, improve cognitive impairment and clinical symptoms in neuropsychiatric diseases. In this article, we review the recent findings on sigma-1 receptor agonists as potential therapeutic drugs for the treatment of cognitive impairment in schizophrenia and psychotic depression.


hey look over here! A2-73..Sigma 1 Agonixt with Muscarinic..
Mighty fine Combo
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News